ArticleResearch in autism spectrum disorders2021
COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study.
Article in Research in autism spectrum disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 15 citations in OpenAlex.
- Assessing Adherence to Preventive Behaviors Among Patients with Mental Illness in the Context of the COVID-19 Pandemic: A Scoping Review.International journal of environmental research and public health · 2026Article
- Content Analysis of Abstracts Published in Autism Journals in 2021: The year in Review.Journal of autism and developmental disorders · 2023Article
- A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities.Vaccines · 2023Article
- Impact of the COVID-19 Pandemic on Autistic Adults: a Scoping Review.Current developmental disorders reports · 2023Article
- Antivax attitude in the general population along the autism-schizophrenia continuum and the impact of socio-demographic factors.Frontiers in psychology · 2023Article
- Effects of COVID-19 on children with autism.World journal of virology · 2022Review
- [Autism Spectrum Disorders: What the COVID-19 Pandemic Has Taught Us].Annales medico-psychologiques · 2022Article
- A Pediatrician's Guide to Working with Children on the Autism Spectrum in Coronavirus Disease 2019 and Beyond: Retrospect and Prospect.Advances in pediatrics · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndividuals with autistic spectrum disorder (ASD) are more susceptible to COVID-19 morbidity and should therefore be prioritized for vaccination. Although individuals with neurodevelopmental disabilities are given some priority in Israel, it is unclear to what extent individuals with ASD are being vaccinated relative to that of the general population. This study was aimed to assess vaccination prevalence among individuals with ASD.
methodIndividuals with ASD, and age- and sex-matched controls (total
resultsIndividuals with ASD were more likely to be vaccinated for COVID-19 (
conclusionsEfforts to prioritize ASD patients may improve vaccination prevalence among individuals with ASD, especially among younger individuals. Healthcare providers worldwide should therefore consider prioritization policies so as to increase vaccination rates among this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.